Company

Henlius Biotech Forecasts First-Ever Profit in 2023 Driven by Sales Growth and Efficient Management

CompanyDeals

Nuance Pharma Wins Arbitration, Rescinds Licensing Deal with Antibe Therapeutics

CompanyDrug

Aosaikang’s Marketing Approval Filing for Delafloxacin Accepted by China’s NMPA

CompanyDeals

Vivolight Medical Secures Over RMB 100 Million in Strategic Financing to Boost Global Expansion

CompanyDrug

Huadong Medicine’s Arcalyst Filing for Recurrent Pericarditis Accepted by China’s NMPA

CompanyMedical Device

Sino Medical Sciences Receives Hong Kong Approval for HT Supreme Drug-Eluting Stent System

CompanyDrug

Hengrui Pharmaceuticals Gets NMPA Green Light for KRAS G12C Inhibitor Clinical Trial in Advanced Solid Tumors

CompanyDrug

HitGen Secures CDE Approval for Lipisense IND Filing, Advancing Development for Dyslipidemia Treatment

CompanyDrug

ViiV Healthcare Presents Phase I Data for Ultra-Long-Acting Cabotegravir in HIV Treatment and Prevention

CompanyDeals

Merck Teams Up with C4 Therapeutics for Targeted Protein Degraders in Oncology

CompanyDigital

Innovent Biologics’ Taletrectinib Receives Second NDA Acceptance in China for ROS1 Positive NSCLC

CompanyDrug

BMS Reports Positive Long-Term Data for Zeposia in Multiple Sclerosis Trials